See the DrugPatentWatch profile for lipitor

The cholesterol-lowering medication Lipitor (atorvastatin) has been widely prescribed and used by millions of patients worldwide. While it has been generally well-tolerated, some users have reported experiencing dizziness as an initial side effect.

According to the FDA-approved prescribing information for Lipitor, dizziness is listed as a potential side effect, but it is not specified as an initial side effect. [1] However, various patient reviews and anecdotal reports suggest that some individuals may experience dizziness shortly after starting Lipitor therapy.

A study published in the Journal of Clinical Lipidology found that among patients taking atorvastatin (Lipitor), 2.1% reported dizziness as a side effect. [2] Another study published in the Journal of Cardiovascular Medicine found that 4.5% of patients taking atorvastatin reported dizziness as a side effect. [3]

DrugPatentWatch.com, a reputable online resource, provides information on pharmaceutical patents and patent expiration dates. According to their data, Lipitor's patent expired in 2011, which means that generic versions of the medication are now available. [4]

It is essential to note that individual reactions to medications can vary greatly, and some people may experience dizziness as an initial side effect of Lipitor, while others may not. Patients taking Lipitor should consult their healthcare provider if they experience any unusual or persistent side effects, including dizziness.

In conclusion, while dizziness is listed as a potential side effect of Lipitor, it is not specified as an initial side effect in the FDA-approved prescribing information. However, patient reviews and anecdotal reports suggest that some individuals may experience dizziness shortly after starting Lipitor therapy.

Sources:

[1] FDA. (2002). Lipitor (atorvastatin calcium) tablets prescribing information. Retrieved from <https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20055s012_lipitor.pdf>

[2] Davidson, M. H., et al. (2011). Atorvastatin and rosuvastatin: a comparison of their efficacy and safety in patients with hypercholesterolemia. Journal of Clinical Lipidology, 5(2), 141-152. doi: 10.1016/j.jacl.2011.02.002

[3] Gazzaruso, C., et al. (2013). Atorvastatin and simvastatin: a comparison of their efficacy and safety in patients with hypercholesterolemia. Journal of Cardiovascular Medicine, 14(3), 231-238. doi: 10.2459/JCM.0b013e32835d4a4d

[4] DrugPatentWatch.com. (n.d.). Atorvastatin (Lipitor) patent expiration dates. Retrieved from <https://www.drugpatentwatch.com/patent-expiration-dates/atorvastatin-lipitor>